Opens in a new tab

ALD France v Nanoval (CFI, 26 January 2026)

Date26 January 2026
CourtCFI
DivisionParis (FR) Central Division - Seat
Type of actionRevocation Action
Case number(s)UPC_CFI_99/2025
Registry referenceUPC-CFI-99/2025
PartiesALD France S.A.S v. Nanoval GmbH & Co. KG

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 26 January 2026 (UPC_CFI_999/2025), the panel of the Paris Central Division upheld on review the dismissal of Nanoval’s preliminary objection to ALD France’s revocation action against EP 3 083 107. Nanoval argued that the action duplicated the counterclaim for revocation brought by the parent company, ALD Vacuum Technologies, pending before the Munich Local Division. The order clarifies the concept of the « same party » in Art. 33(4) UPCA within a group of companies.

Question

May a subsidiary bring a revocation action before the Central Division where its parent company has already counterclaimed for revocation before a local division, and should the proceedings be stayed?

Decision

The subsidiary and the parent are not the same party (paragraph 34). Identity requires the parties to be identical or their interests to coincide to such an extent that a judgment against one would be res judicata against the other (paragraph 36). The indicators of a straw man, namely lack of its own assets and employees, are absent (paragraph 38), and neither the parent-subsidiary link nor the degree of control is decisive (paragraph 40). Nanoval did not prove that ALD France had no business of its own (paragraph 44). The order in which the actions were filed is irrelevant (paragraph 45). A stay under Rule 295(m) was refused: the risk of conflicting decisions is inherent in the system and the Munich hearing is due in June 2026 (paragraphs 48 to 50). Leave to appeal was refused (paragraph 51).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 33(4)
Rules of Procedure
Rules 19, 171.1, 295 and 333
Regulation (EU) No 1215/2012
Art. 29
Case law cited
Edwards Lifesciences v Meril Italy, Paris Central Division, 13 November 2023, Seoul Viosys v Emporia UK, Paris Central Division, 1 September 2025, Netgear v Huawei, Court of Appeal, 21 March 2024, Court of Appeal, 25 November 2025, UPC_CoA_464/2024 and others, Court of Appeal, UPC_CoA_22/2024, CJEU, 19 May 1998, C-351/96, CJEU, 10 September 2009, C-97/08

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Revocation action.

Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_99/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Revocation Action
Outcome (Dhenne Avocats summary)
Le rejet de l'exception préliminaire est confirmé : la filiale ALD France n'est pas la même partie que sa société mère au sens de l'article 33, paragraphe 4, de l'Accord, et aucun sursis n'est accordé.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 083 107Mentioned in the analysis (role not qualified)
Also mentioned in 4 other decision(s): ALD France v Nanoval (CFI, 23 July 2026) · ALD France v Nanoval (CFI, 9 December 2025) · Nanoval v ALD Vacuum Technologies (CFI, 22 July 2025) · Nanoval v ALD Vacuum Technologies (CFI, 28 May 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.